JP2004018512A - Poor circulation-improving composition and use of cacao bean processed product for producing the poor circulation-improving composition - Google Patents
Poor circulation-improving composition and use of cacao bean processed product for producing the poor circulation-improving composition Download PDFInfo
- Publication number
- JP2004018512A JP2004018512A JP2002180493A JP2002180493A JP2004018512A JP 2004018512 A JP2004018512 A JP 2004018512A JP 2002180493 A JP2002180493 A JP 2002180493A JP 2002180493 A JP2002180493 A JP 2002180493A JP 2004018512 A JP2004018512 A JP 2004018512A
- Authority
- JP
- Japan
- Prior art keywords
- improving
- poor circulation
- effect
- composition
- cocoa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000299461 Theobroma cacao Species 0.000 title claims abstract description 78
- 244000046052 Phaseolus vulgaris Species 0.000 title claims abstract description 51
- 235000010627 Phaseolus vulgaris Nutrition 0.000 title claims abstract description 51
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 title abstract description 7
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 title abstract description 7
- 235000001046 cacaotero Nutrition 0.000 title abstract description 7
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 69
- 238000001816 cooling Methods 0.000 claims description 36
- 239000000843 powder Substances 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 28
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 14
- 235000015097 nutrients Nutrition 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 229910052742 iron Inorganic materials 0.000 abstract description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract description 6
- 210000003403 autonomic nervous system Anatomy 0.000 abstract description 6
- 239000011777 magnesium Substances 0.000 abstract description 6
- 229910052749 magnesium Inorganic materials 0.000 abstract description 6
- 244000269722 Thea sinensis Species 0.000 abstract description 5
- 235000016213 coffee Nutrition 0.000 abstract description 5
- 235000013353 coffee beverage Nutrition 0.000 abstract description 5
- 235000009569 green tea Nutrition 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 230000001882 diuretic effect Effects 0.000 abstract description 2
- 230000006996 mental state Effects 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 230000000304 vasodilatating effect Effects 0.000 abstract description 2
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 206010016326 Feeling cold Diseases 0.000 description 34
- 239000000047 product Substances 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 230000006872 improvement Effects 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 230000035622 drinking Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 235000010755 mineral Nutrition 0.000 description 8
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 238000001931 thermography Methods 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- -1 arachidonic acid ester Chemical class 0.000 description 6
- 239000000306 component Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 4
- 240000006891 Artemisia vulgaris Species 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 229960004559 theobromine Drugs 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 235000002566 Capsicum Nutrition 0.000 description 3
- 240000008574 Capsicum frutescens Species 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000002964 excitative effect Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 240000002234 Allium sativum Species 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 235000012171 hot beverage Nutrition 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940075420 xanthine Drugs 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 206010034567 Peripheral circulatory failure Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- IAIWVQXQOWNYOU-BAQGIRSFSA-N [(z)-(5-nitrofuran-2-yl)methylideneamino]urea Chemical compound NC(=O)N\N=C/C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-BAQGIRSFSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Natural products CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 231100000877 autonomic nervous system dysfunction Toxicity 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 235000021268 hot food Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000019263 trisodium citrate Nutrition 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
- 230000009724 venous congestion Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は、冷え性改善用組成物、特に、カカオ豆加工物を含むことを特徴とする冷え性改善用組成物に関し、更に、冷え性改善用組成物の製造のためのカカオ豆加工物の使用に関する。
【0002】
【従来の技術】
従来から、冷え性に悩まされる人の数は少なくない。冷え性の原因としては幾つかの理由が考えられているが、特に、近年の急速な生活環境の変化に伴い冷え性を訴える人の数は急増しているといわれている。
【0003】
例えば、冷え性の主な原因の1つには、皮膚に存在する温度を感じる神経の機能が低下し、当該温度に関する情報が有効に脳に伝達されないことがあげられている。特に、近年の冷暖房完備の生活条件下では、1年中を通して居住室内の温度が一定となった反面、室内外の温度差が著しい。そのために、身体の季節適応力も低下し、またこのような急激な温度差のある生活を続けることで、気温変化に順応するための神経伝達系の機能も低下してきているといわれる。更には、冬季も夏季と同様に冷たい飲料や食品を摂取する機会が増加し、内臓の温度調節機能を低下してきていると指摘されている。
【0004】
その他の要因による自律神経系の失調、すなわち自律神経の機能低下および自律神経系から体温調節のための指令が身体の各器官にうまく伝わらないことも上記の原因と密接に関連付けられる。特に、ストレスの多い環境下においては自律神経の機能が低下するといわれており、また女性の冷え性では、女性ホルモンの分泌を制御する神経と当該自律神経が密接な関係にあるとされることから出産や閉経時に自律神経のバランスが崩れて冷え性が誘発される場合が多いと考えられている。
【0005】
更に第2の原因としては血行動態の悪化があげられている。すなわち、血流が悪いために身体の末端にまで血液が行き渡らないことにより身体が冷えるのである。例えば、低血圧のために温かい血液が毛細血管にまで行き届かないことが考えられ、栄養不足や無理なダイエットによる貧血がそのような低血圧を助長し得る。また、静脈のうっ血により暖められた動脈の血液が体中に行き渡るまでに冷えてしまうことや、特に中年男性の冷え性においては動脈硬化等で血管が細くなり、末端の毛細血管の血流が低下すると考えられている。
【0006】
通常の食生活において上記のような冷え性を改善するためには、以下のような栄養素や食品成分を摂取することが推奨されている。
【0007】
まず、長期的に冷え性を改善するような栄養素として鉄分を摂取することがあげられる。鉄分はヘモグロビンの成分であり、身体中に酸素を送り届ける赤血球やヘモグロビンが少ない状態だと、各器官に送られる酸素量が少ないため細胞での栄養の燃焼が不完全となり、熱の産生が低下して全身の冷えが助長される。次にマグネシウムの摂取も推奨される。マグネシウムはヘモグロビンの変形能を向上させることによる血流改善効果があり、更には生体でのエネルギー生産に関与して基礎代謝の向上につながる。また、ビタミンCも、上記の鉄の吸収を促進するとともに、正常の血管構造を保持する作用がある。更に、ビタミンEおよびその誘導体は、血行を良くし、体内のホルモン分泌を調整する働きがある。
【0008】
その他、代謝を向上させるものとしてトウガラシやニンニクに代表される各種の香辛料が有効とされ、これらは血管拡張や体脂肪の燃焼促進効果により体温を上昇させる。また、東洋医学ではウーロン茶が推奨されている。
【0009】
上記の通常の食生活上の注意による方法以外にも、様々な冷え性の改善方法が提案されている。
【0010】
特開昭60−160856号広報には、タンポポとヨモギとをゲル状(エキス状)にしたゲル状物、タンポポとヨモギの粉体の混合物、タンポポの粉体或いはヨモギの粉体のいずれか一つとタンポポをゲル状にした物或いはヨモギをゲル状にした物との混合物のいずれかに少なくとも黒焼を所定量混合して形成した健康食品が開示されており、当該健康食品は浄血、造血、整腸、健胃、潰瘍の治癒、排便促進効果、虚証タイプの冷え症の解決、血行障害の改善等に有効とされる。
【0011】
特開平1−216925号広報には、アラキドン酸エステルを有効成分とする外用の冷え改善剤が開示されている。「お血」(血液の流れに障害をきたし、スムーズに流通しなくなり、或いは脈管外に漏出して血の作用をはたせなくなった状態)による冷えの状態においては組織が慢性的で低酸素、低栄養状態になっているが、このような冷えの状態に当該改善剤を施すと、血流促進作用により酸素や栄養を供給することができ、老廃物がすみやかに除去されると共に、熱の運搬に大きな影響をあたえ、冷えを解消するとされる。
【0012】
特開平6−305976号公報には、熟地黄の30%以上のエタノール抽出エキスを有効成分として含有することを特徴とする血流改善剤が開示され、当該改善剤は、血球成分の中で最も血流量に影響を及ぼすものの一つである赤血球変形能を高め、造血作用を有し、アジュバント関節炎ラットに惹起される赤血球変形能の低下、貧血の発現、血管、皮膚での結合組織の増殖を有意に抑制し、線溶系活性化作用を有し、その結果静脈血流を増加するので、虚弱体質、疲労、冷え症、肩こり等の末梢循環不全による疾患の改善、治療に有効であるとされる。
【0013】
特開平11−158065号公報には、基剤中に温感誘起物質を含有し、足裏に適用する経皮吸収製剤であって、冷え性および/または足の冷えを適応症とすることを特徴とする経皮吸収製剤が開示され、当該温感誘起物質としてはトウガラシエキスやカプサイシン等が例示されている。そして、当該経皮吸収製剤は、これを足裏に適用することにより、経皮吸収製剤中の温感誘起物質の作用により身体中の血液の循環が促され、冷え性や足の冷えに対して優れた治療効果を有するとされる。
【0014】
特開平11−243913号公報には、原材料としてサンザシ、ケイヒ、ウイキョウ、ウコン、エビスグサ、イチョウ、クコ、トウガラシ、ゴマ、ショウガ、クワ、の内の少なくとも六種類以上の組み合わせからなる粉末状、顆粒状、ペースト状、錠剤状、カプセル状、軟カプセル状、液体状の薬膳調味栄養食品が開示されている。当該栄養食品は、成人病対策としての高血圧・高コレステロール、糖尿病等の防止、または女性の冷え性・生理痛・便秘・肥満等をその処方の目的としている。
【0015】
特開2001−348334号公報には、ガラナ、マカエキス、プラセンタ、プエラリアおよびカバエキスを主有効成分とする栄養剤が開示されている。当該栄養剤は、従来にくらべて、滋養強壮、疲労回復、体力増強、肝機能向上、強精、神経痛の改善、冷え性の改善、血行不全の改善、記憶力の改善等の効能、作用が著しく向上するとされる。
【0016】
上記の各公報に開示される冷え、冷え症或いは冷え性の改善方法は主に血流障害の改善をその重要な作用機序の1つとしているが、当該血流障害のみならず様々な理由により、近年、益々、拡大する冷え性の改善を、簡便且つ安全に達成する手段を提供することは意義深い。
【0017】
【発明が解決しようとする課題】
したがって、本発明は、広く、血流障害のみならず、皮膚に存在する温度を感じる神経の機能低下を含む自律神経系の失調等によってももたらされ得る冷え性を、簡便且つ安全に改善する手段を提供することを目的とする。
【0018】
【課題を解決するための手段】
本発明者等は、カカオ豆加工物の様々な生理作用を明らかにする中で、当該カカオ豆加工物が優れた冷え性改善効果(体表面温度上昇効果)を有することを見出した。カカオ豆にはキサンチン系の化合物であるテオブロミンが多く含まれるが、当該テオブロミンは同じキサンチン系の化合物であるカフェインやテオフィリンに比較して極めて温和で微弱な中枢神経興奮作用を有するに過ぎない。しかしながら、驚くべきことに、当該テオブロミンの弱い中枢神経興奮作用、とりわけ軽微な覚醒・興奮作用にも拘らず、それを含むカカオ豆加工物が上記カフェインやテオフィリンを多く含むコーヒーやお茶に比べていっそう優れた冷え性改善効果を有することが見出されたのである。また、カカオ豆由来の成分による血流障害改善効果、例えば血管拡張作用や、それによる利尿作用等も同時に期待されるのでその効果の持続性も期待され、更には、上記のように冷え性の中〜長期的な改善に有効とされる栄養素である鉄分やマグネシウムが豊富に含まれており、加えてリラックス効果による精神状態の安定によりストレスの軽減も期待されるので、カカオ豆加工物は、その個々の特定成分のみならず全体としても理想的な冷え性改善効果を発揮すると考えられる。したがって、本発明の第1は、
(1)カカオ豆加工物を含むことを特徴とする冷え性改善用組成物である。
【0019】
カカオ豆加工物としては種々の形態のものが知られているが、特にココアパウダーは粉末状であり且つ風味も優れており、各種形態の組成物への加工性に適しているので、当該ココアパウダーが本発明のカカオ豆加工物として好適に利用できる。したがって、本発明の第2は、
(2)前記カカオ豆加工物がココアパウダーである上記(1)の冷え性改善用組成物である。
【0020】
本発明の冷え性改善用組成物は食品或いは薬剤の形態となし得る、したがって本発明の第3および第4は、
(3)食品の形態で投与される上記(1)または(2)の冷え性改善用組成物、および
(4)薬剤の形態で投与される上記(1)または(2)の冷え性改善用組成物である。
【0021】
上記に関連して、本発明の別の側面では、優れた効果を有する冷え性改善用組成物の製造方法も提供される。すなわち、本発明の第5乃至第8は、
(5)冷え性改善用組成物の製造のためのカカオ豆加工物の使用、
(6)前記カカオ豆加工物がココアパウダーである上記(5)の使用、
(7)前記組成物が食品である上記(5)または(6)の使用、および
(8)前記組成物が薬剤である上記(5)または(6)の使用である。
【0022】
本発明によれば、実際の冷え性の症状や兆候の改善のみならず、当該冷え性の予防や、特に冷房病ともいわれる外部との温度差が激しい夏季の室内環境に起因する身体等の失調、或いは冬季における室内外の温度差に起因する冷え性も含めて、それらを極めて簡便に改善することができ、したがって、本発明の冷え性改善用組成物は、具体的な冷え性の改善のみならず健常者においてもその健康状態の維持・増進に役立てることができる。
【0023】
【発明の実施の形態】
本明細書で用いる「カカオ豆加工物」の用語は、生のカカオ豆或いは焙炒したカカオ豆から調製されたものを包含することを意図する。カカオ豆から調製されたカカオ豆加工物の例には、生の或いは焙炒したカカオ豆を粗砕または粉砕したものや当該粉砕物等から更にカカオバターを搾油したもの等のほか、例えば任意に付加的な加熱処理或いはpH調整のための各種塩溶液処理を施したもの、更には上記のものからの抽出物(例えば、テオブロミン)も含まれる。原料のカカオ豆はシェルやジャームを含んでいてもよく、またそれらが除去されたカカオニブの形態であってもよい。好ましい本発明のカカオ豆加工物の例は、シェルおよびジャームを除去した後に焙炒されたカカオ豆を磨砕、搾油、粗砕、微粉砕して得られるものを含む。本発明において特に好ましいカカオ豆加工物はココアパウダーであり、当該ココアパウダーは例えば森永製菓株式会社より商品名「ピュアココア」としても市販されている。
【0024】
本発明の冷え性改善用組成物は、上記のカカオ豆加工物を冷え性改善のための有効成分として含有する。本発明の冷え性改善用組成物に添加されるカカオ豆加工物の添加量は、当該組成物の所望の品質・特性等によって適宜調節することができ、またその形態によってはカカオ豆加工物単独で本発明の冷え性改善用組成物を構成してもよいが、一般的には組成物の総量に対して1乃至90重量%、好ましくは1乃至20重量%、より好ましくは1乃至8重量%程度の添加量で配合される。
【0025】
上記のとおり、食餌による冷え性の中〜長期的な改善には鉄分やマグネシウムといったミネラル、ビタミンCやビタミンEに代表される各種ビタミン類の補給が有効であるとされている。ここで、カカオ豆加工物には一般的に十分な量のミネラルが含まれているので敢えてそれを補強する必要はないが、場合によってはこれらのミネラルやビタミン類も本発明の組成物に更に任意に含めることができる。この場合、それらの付加的に配合される栄養素は、カカオ豆加工物に本来から含有されている当該栄養素を更に補強しおよび/または当該栄養素以外のカカオ豆成分による持続性を有する比較的短期的な効果を更に助長するのに有効である。同様に、血行改善作用や代謝促進作用が知られているような香辛料類(トウガラシ、ニンニク等)やその有効成分もまた本発明の組成物に任意に配合してよい。
【0026】
本発明の冷え性改善用組成物に付加的にミネラルやビタミン類を配合する場合、その配合量も、当該組成物の形態や目的とする品質・特性、更にはそれが投与される対象者の年齢や性別、冷え性の症状の有無等に応じて、適宜、調節することができる。
【0027】
本発明の食品形態である冷え性改善用組成物は、各種の食品にカカオ豆加工物、好ましくはココアパウダーを添加することで容易に製造することができ、上記のとおり当該組成物には更に付加的に鉄分やマグネシウムといったミネラル、ビタミンC、Eといったビタミン類および/または香辛料等が配合されてもよい。そのようなカカオ豆加工物の添加や、任意的なミネラル・ビタミン類の配合には当業者に公知・慣用のいかなる技術を用いてもよく、また当該配合に適した食品の組成も当業者に公知のいかなるものを用いてもよい。
【0028】
例えば、本発明の冷え性改善用組成物はインスタントココアやチョコレートのような食品の形態とすることができ、その場合、該インスタントココアの例では、冷え性改善効果を有するココアパウダー15重量%に、砂糖54重量%、全脂粉乳10重量%、脱脂粉乳20重量%、食塩0.5重量%、香料0.5重量%が配合される。また、チョコレートも当業者に公知のいかなる方法によって製造してもよく、そこにおいても付加的にミネラルやビタミン、或いは香辛料等を任意に配合してよい。
【0029】
また、本発明の冷え性改善用組成物は経口の薬剤等として調製することができる。
【0030】
すなわち、本発明のカカオ豆加工物は優れた冷え性改善(体表面温度上昇)作用を有するので、当該カカオ豆加工物、例えばココアパウダーに、更に薬学的に許容される添加剤を加えて或いは他の有効成分と共に製剤とすることができる。その際の添加剤としては、製剤分野において通常用いられる各種の添加剤が使用可能であり、例えば、ゼラチン、乳糖、白糖、酸化チタン、澱粉、結晶セルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース、コーンスターチ、マイクロクリスタリンワックス、白色ワセリン、メタケイ酸アルミン酸マグネシウム、無水リン酸カルシウム、クエン酸、クエン酸三ナトリウム、ヒドロキシプロピルセルロース、ソルビトール、ソルビタン脂肪酸エステル、ポリソルベート、ショ糖脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリビニルピロリドン、ステアリン酸マグネシウム、軽質無水ケイ酸、タルク、植物油、ベンジルアルコール、アラビアガム、プロピレングリコール、ポリアルキレングリコール、シクロデキストリンまたはヒドロキシプロピルシクロデキストリン等が挙げられる。
【0031】
これらの添加剤との混合物として、或いは更に任意の他の有効成分を含み得る混合物として製剤化される剤形としては、例えば、錠剤、カプセル剤、顆粒剤、散剤等の固形製剤;または例えばシロップ剤やドリンク剤を含む経口内服剤等の液体製剤が挙げられ、これらは、製剤分野における通常の方法によって調製することができる。なお、シロップ剤等の液体製剤にあっては、用時に水または他の適当な媒体に溶解または懸濁させる形であってもよい。
【0032】
これらの製剤は、本発明のカカオ豆加工物を、全薬剤の1〜90重量%、好ましくは1〜20重量%の割合で含有することができる。
【0033】
かくして、本発明のカカオ豆加工物を含むことを特徴とする各種態様の冷え性改善用組成物が製造され、冷え性改善処置が必要とされる対象者の治療・予防のみならず健常者の健康維持・増進に役立てることができる。
【0034】
以下、実施例により本発明を詳細に説明するが、実施例は本発明を何ら限定するものではない。
【0035】
【実施例】
実施例1:カカオ豆加工物による体表面温度上昇効果
夏季の冷房室内での冷え性も想定して、気温を25℃に設定した室内での安静時の体表面温度変化に対する本発明のカカオ豆加工物摂取の効果を検討した。なお、夏季の冷房温度としては一般に28℃が推奨されているが、現実には、25℃前後に当該冷房温度を設定する場合が全体の60%以上(「温度は特に設定せず」を含めて)を占めるという調査結果もあり、本実施例では効果を明確にする等の目的を含めてそのようなやや過度の冷房時を想定した。
【0036】
冷え性の自覚のない被験者を含む12名の女性を対象に本試験を行った。当該試験において被験者は試験開始2.5時間前からの飲食が禁止され、また試験当日の朝・昼食時の刺激物の摂取も禁止された。試験は、まず被験者を25℃に温度調節した部屋で30分間安静に待機させて初回の体表面温度を測定した後、試験飲料を飲用させて、その後、5分毎に体表面温度の変化を記録することで行なった。なお、試験中、被験者は安静にし、話したり、動き回ったり、或いは寝ることのないように指示された。また、試験飲料の飲用5分前から一定の姿勢を維持し、以後、その姿勢で測定が実施され、特に、測定部位である手の体表面温度が他の因子による影響を受けないように、すなわち手の部分がどこにも触れないようにするために、アーム付椅子のアームに手首から先が触れないような体勢で当該アームに腕をかけて座るように指示された。更に、室内における被験者の待機位置は、エアーコンディショナーの送風が直接あたらない場所とされ、該送風量も最も微弱なものとした。室内は、安静状態を保つために照明を薄明かりとし、1分間に60カウントでメトロノームを設置して平穏な環境とした。
【0037】
試験は、70乃至75℃の市販ココア(商品名「カカオ極立つ贅沢なココア」、森永製菓株式会社製、製造元の指示どおり作製)、コーヒー(市販インスタントコーヒー粉末1g、グラニュー糖3g、市販クリーミーパウダー3gを100mlのお湯に溶解)、緑茶(市販煎茶飲料水)およびお湯について行い、被験者はこれらの温飲料の100mlを適宜冷ましながら飲用した。飲用においては、羽付の紙コップを用い、該コップの持ち手と逆の手はコップに添えないように指示された。なお、被験者のうちの3名はコーヒーを飲むことができないため、当該被験者ではコーヒーによる試験を行なわなかった。体表面温度の測定は、医用サーモグラフィー装置(機種名:インフラアイ2000、富士通特機システム株式会社製)を用いて実施した。
【0038】
サーモグラフィーで測定した冷え性改善に関する評価の概略を表1に示した。また、サーモグラフィーの測定結果を画像解析し、体表面温度の推移を算出した結果の各被験者間の平均を図1に示した。更に図2には被験者K.A.における実際のサーモグラフィーの測定例を示した。
【0039】
【表1】
【0040】
上記のようにしてサーモグラフィーにより体表面温度の上昇程度およびその持続時間を評価したところ、表1のとおり、本発明のカカオ豆加工物を含むココアが優れた冷え性改善効果を奏することが示された。試験では、ココアの効果が緑茶のそれとほぼ同等な例(W.T.)やコーヒーの効果と同等の例(T.M.)、或いは緑茶の方がやや優れた例(I.M.)等の若干の例外も見受けられたが、被験者の殆どがカカオ豆加工物の摂取により最も優れた冷え性の改善を経験した。
【0041】
また、図1からは、体表面温度の試験において、当該試験飲料の飲用後の体表面温度推移が解るが、総じて、被験者は試験飲料の飲用後5分前後に一旦、体表面温度が低下する。その後、10分から20分後にかけて熱いものを摂取した影響等で体表面温度が上昇するが、本発明のカカオ豆加工物を含むココアの場合その上昇を維持する時間が長く、また、飲用後40分程度で再度、体表面温度の上昇が観察される。ココアと同様な体表面温度の変化傾向はココア以外でも認められる場合があるが、総じて温度上昇時間が短く、また、カカオ豆加工物で認められる40分前後の後期体温上昇が観測されないか、観測されても微弱なものに過ぎなかった。特にココア以外の飲料では、飲用開始後約30分以前には平均の体表面温度が飲用開始前のそれを下回っているが、ココアにおいては飲用後60分においてもそのような体表面温度の低下が認められなかったことは特筆に値する。
【0042】
以上の結果から、本発明のカカオ豆加工物が優れた冷え性改善効果を有することが実証された。
【0043】
【発明の効果】
本発明によれば、実際の冷え性の症状や兆候の改善のみならず、当該冷え性の予防や、特に冷房病ともいわれる外部との温度差が激しい夏季の室内環境に起因する身体等の失調、或いは冬季における室内外の温度差に起因する冷え性も含めて、それらを極めて簡便に改善することができ、したがって、本発明の冷え性改善用組成物は、具体的な冷え性の改善のみならず健常者においてもその健康状態の維持・増進に役立てることができる。
【図面の簡単な説明】
【図1】サーモグラフィーの画像解析に基づく各種温飲料飲用後の体表面温度推移の平均を示す。
【図2】被験者K.A.におけるサーモグラフィーの測定例の図面代用写真。[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a composition for improving cooling performance, particularly to a composition for improving cooling performance characterized by containing a processed cocoa bean product, and further relates to use of the processed cocoa bean product for producing the composition for improving cooling performance.
[0002]
[Prior art]
Conventionally, the number of people suffering from coldness is not small. There are several possible reasons for the chilliness, and it is said that the number of people who complain of chilliness has increased rapidly, especially with the recent rapid changes in living environment.
[0003]
For example, one of the main causes of coldness is that the function of nerves that sense temperature existing in the skin is reduced, and information about the temperature is not effectively transmitted to the brain. In particular, under living conditions with air conditioning and heating in recent years, the temperature inside the living room has become constant throughout the year, but the temperature difference between the room and the outside is remarkable. For this reason, it is said that the body's ability to adapt to the season has also declined, and that the function of the neurotransmitter system for adapting to changes in temperature has also declined by continuing to live with such a rapid temperature difference. Furthermore, it is pointed out that in winter, as in summer, the opportunity to ingest cold beverages and foods has increased, and the temperature regulation function of the internal organs has been reduced.
[0004]
The autonomic nervous system dysfunction due to other factors, that is, the deterioration of the autonomic nervous system and the inability of the autonomic nervous system to transmit a command for controlling the body temperature to each organ of the body are also closely related to the above-mentioned causes. In particular, it is said that the function of the autonomic nervous system is reduced in a stressful environment, and that in women with coldness, it is said that the autonomic nervous system is closely related to the nerve that controls the secretion of female hormones. It is often thought that the balance of the autonomic nerves is disrupted during menopause and chills are induced.
[0005]
A second cause is deterioration of hemodynamics. That is, since the blood does not reach the end of the body due to poor blood flow, the body cools. For example, it is possible that warm blood does not reach the capillaries due to hypotension, and undernutrition or anemia due to overweight diet can promote such hypotension. In addition, blood in the artery warmed by venous congestion cools before it reaches the whole body, and especially in the coldness of middle-aged men, blood vessels become thin due to arteriosclerosis and the blood flow in the capillaries at the ends is reduced. It is thought to decline.
[0006]
In order to improve the above-mentioned chilliness in normal eating habits, it is recommended to ingest the following nutrients and food components.
[0007]
The first is to take iron as a nutrient that improves chilling in the long term. Iron is a component of hemoglobin, and when there are few red blood cells and hemoglobin that deliver oxygen to the body, the amount of oxygen sent to each organ is small, so the burning of nutrients in cells is incomplete and heat production is reduced. The whole body gets cold. Next, magnesium intake is also recommended. Magnesium has an effect of improving blood flow by improving the deformability of hemoglobin, and further contributes to energy production in a living body, leading to improvement of basal metabolism. Vitamin C also has the effect of promoting the absorption of iron and maintaining a normal vascular structure. Furthermore, vitamin E and its derivatives have the effect of improving blood circulation and regulating hormone secretion in the body.
[0008]
In addition, various spices typified by capsicum and garlic are effective for improving metabolism, and they increase body temperature by vasodilation and the effect of promoting body fat burning. Oriental medicine recommends oolong tea.
[0009]
Various methods for improving coldness have been proposed in addition to the method based on the usual dietary precautions described above.
[0010]
Japanese Patent Application Laid-Open No. 60-160856 discloses a gel (extract) of dandelion and mugwort, a mixture of dandelion and mugwort powder, one of dandelion powder and mugwort powder. A health food formed by mixing at least a predetermined amount of black porcelain in one of a mixture of a dandelion in a gel or a mugwort in a gel is disclosed, and the health food is blood purification, hematopoiesis, It is said to be effective in healing intestines, stomachic, healing of ulcers, promoting defecation, solving false-positive type coldness, improving blood circulation disorders, and the like.
[0011]
Japanese Patent Application Laid-Open No. 1-216925 discloses an external cooling improver containing an arachidonic acid ester as an active ingredient. Tissues are chronic and hypoxic in the cold state due to "blood" (a state in which the blood flow is impaired, the blood does not flow smoothly, or the blood leaks out of the vessel, and the blood cannot work). However, when it is in a low nutritional state, when the improving agent is applied to such a cold state, oxygen and nutrients can be supplied by a blood flow promoting action, and waste products are promptly removed, and heat is removed. It is said that it will have a major effect on the transportation of refrigeration, and will eliminate the cold.
[0012]
JP-A-6-305076 discloses a blood flow improving agent characterized by containing an ethanol extract of 30% or more of matured yellowish yellow as an active ingredient, and the improving agent is the most effective blood cell component among blood cell components. Increases erythrocyte deformability, which is one of the factors affecting blood flow, has hematopoietic effects, reduces erythrocyte deformability induced by adjuvant arthritis rats, develops anemia, and proliferates connective tissue in blood vessels and skin. It significantly suppresses and has a fibrinolytic activation effect, and as a result increases venous blood flow, it is said to be effective in ameliorating and treating diseases due to peripheral circulatory failure such as weak constitution, fatigue, coldness, stiff shoulders .
[0013]
Japanese Patent Application Laid-Open No. 11-158065 discloses a percutaneous absorption preparation which contains a warming-inducing substance in a base and is applied to the sole of a foot, characterized in that coldness and / or coldness of the foot are indicated. Transdermal preparations are disclosed, and as the warming-inducing substance, pepper extract, capsaicin and the like are exemplified. Then, by applying the percutaneous absorption preparation to the sole of the foot, the circulation of blood in the body is promoted by the action of the warming-inducing substance in the percutaneous absorption preparation, and the chilliness and cooling of the feet are prevented. It is said to have an excellent therapeutic effect.
[0014]
JP-A-11-243913 discloses that raw materials such as hawthorn, calyx, fennel, turmeric, prawns, ginkgo, wolfberry, capsicum, sesame, ginger, and mulberry are powdered and granulated from a combination of at least six or more of them. , Pastes, tablets, capsules, soft capsules, and liquids have been disclosed. The nutritional food is intended to prevent hypertension, high cholesterol, diabetes, etc. as a countermeasure for adult diseases, or to prescribe women's chills, menstrual cramps, constipation, obesity, etc.
[0015]
JP-A-2001-348334 discloses a nutrient containing guarana, maca extract, placenta, pueraria, and hippo extract as main active ingredients. Compared with conventional nutrients, the effects and effects of nutrient tonic, recovery from fatigue, physical strength enhancement, liver function improvement, tonicity, neuralgia improvement, coldness improvement, blood circulation insufficiency improvement, memory improvement, etc. are significantly improved. It will be done.
[0016]
The methods disclosed in each of the above publications for improving chills, chills or chilliness mainly have an improvement in blood flow disorder as one of its important mechanisms of action, but for various reasons as well as the blood flow disorder, In recent years, it has been significant to provide a means for easily and safely achieving an ever-expanding improvement in coldness.
[0017]
[Problems to be solved by the invention]
Therefore, the present invention is a means for easily and safely improving not only blood flow obstruction but also coldness which can be brought about by dysfunction of the autonomic nervous system including a decrease in the function of nerves that sense temperature existing in the skin. The purpose is to provide.
[0018]
[Means for Solving the Problems]
The present inventors have found that, in clarifying various physiological actions of the processed cocoa bean, the processed cocoa bean has an excellent cooling property improving effect (body surface temperature increasing effect). Cocoa beans contain a large amount of theobromine, a xanthine-based compound, but the theobromine has only a mild and weak central nervous system excitatory effect as compared to the same xanthine-based compounds, caffeine and theophylline. However, surprisingly, in spite of the weak central nervous excitatory action of theobromine, in particular, despite the slight arousal / excitatory action, the cocoa bean processed product containing the same is higher than the coffee or tea containing more caffeine or theophylline. It has been found that the composition has an even better cooling property improving effect. In addition, the effect of cocoa bean-derived components on improving blood flow impairment, such as vasodilatory effect and diuretic effect therefrom, is also expected at the same time, so that the effect is expected to be sustained. ~ It is rich in iron and magnesium, which are nutrients that are effective for long-term improvement, and in addition, it is expected to reduce stress by stabilizing mental state by relaxing effect. It is thought that not only individual specific components but also the whole as a whole exhibit an ideal cooling property improving effect. Therefore, the first of the present invention is:
(1) A composition for improving cooling performance, characterized by containing a processed cacao bean product.
[0019]
Various types of processed cocoa beans are known, and in particular, cocoa powder is powdery and has excellent flavor, and is suitable for processing into compositions of various types. Powder can be suitably used as the processed cocoa bean product of the present invention. Therefore, the second aspect of the present invention is:
(2) The composition for improving cooling properties according to the above (1), wherein the processed cocoa bean is cocoa powder.
[0020]
The composition for improving cooling performance of the present invention can be in the form of food or medicine.
(3) The composition for improving coldness according to (1) or (2), which is administered in the form of food, and (4) the composition for improving coldness according to (1) or (2), which is administered in the form of a drug. It is.
[0021]
In relation to the above, in another aspect of the present invention, there is also provided a method for producing a composition for improving cooling performance having excellent effects. That is, the fifth to eighth aspects of the present invention include:
(5) use of a processed cocoa bean for production of a composition for improving cooling performance;
(6) Use of the above (5), wherein the processed cocoa bean is cocoa powder,
(7) Use of the above (5) or (6), wherein the composition is a food, and (8) Use of the above (5) or (6), wherein the composition is a drug.
[0022]
According to the present invention, not only the improvement of symptoms and signs of actual coldness, but also the prevention of the coldness, especially the ataxia of the body or the like due to the indoor environment in the summer when the temperature difference from the outside, which is also called cooling disease, is severe, or Including the coldness caused by the temperature difference between indoor and outdoor in winter, they can be extremely easily improved.Therefore, the composition for improving coldness of the present invention is not only effective for improving specific coldness but also for healthy people. Can also help maintain and improve their health.
[0023]
BEST MODE FOR CARRYING OUT THE INVENTION
As used herein, the term “cocoa processed product” is intended to include fresh cocoa beans or those prepared from roasted cocoa beans. Examples of cocoa bean processed products prepared from cocoa beans include, for example, those obtained by crushing or pulverizing raw or roasted cocoa beans, those obtained by further crushing cocoa butter from the crushed products, and the like. Also included are those subjected to additional heat treatments or various salt solution treatments for pH adjustment, and also extracts (eg, theobromine) from the above. The raw cocoa beans may include shells and germs, or may be in the form of cocoa nibs from which they have been removed. Preferred examples of the processed cocoa beans of the present invention include those obtained by grinding, oiling, crushing, and pulverizing roasted cocoa beans after removing the shell and germ. A particularly preferred processed cocoa bean product in the present invention is cocoa powder, which is also commercially available, for example, from Morinaga Seika Co., Ltd. under the trade name "Pure Cocoa".
[0024]
The composition for improving cooling performance of the present invention contains the above processed cocoa bean as an active ingredient for improving cooling performance. The amount of the processed cocoa beans added to the composition for improving cooling performance of the present invention can be appropriately adjusted depending on the desired quality and characteristics of the composition, and depending on the form, the processed cocoa beans alone can be used. Although the composition for improving cooling performance of the present invention may be constituted, it is generally about 1 to 90% by weight, preferably about 1 to 20% by weight, more preferably about 1 to 8% by weight based on the total amount of the composition. In the amount added.
[0025]
As described above, supplementation of minerals such as iron and magnesium, and various vitamins typified by vitamin C and vitamin E are effective for improving medium-to-long-term cooling of food. Here, the processed cocoa bean generally contains a sufficient amount of minerals, so there is no need to reinforce it, but in some cases, these minerals and vitamins are further added to the composition of the present invention. Any can be included. In this case, the additional nutrients may be used to supplement the nutrients originally contained in the processed cocoa beans and / or to have a relatively short-term sustainability with cocoa bean components other than the nutrients. It is effective to further promote the effect. Similarly, spices (capsicum, garlic, etc.) whose blood circulation improving action and metabolism promoting action are known, and active ingredients thereof may be arbitrarily added to the composition of the present invention.
[0026]
When minerals and vitamins are additionally added to the composition for improving cooling performance of the present invention, the amount of the minerals and vitamins also depends on the form of the composition, the intended quality / characteristics, and the age of the subject to which it is administered. It can be adjusted as appropriate depending on gender, gender, presence or absence of symptoms of coldness, and the like.
[0027]
The composition for improving the cooling property in the food form of the present invention can be easily produced by adding a processed cocoa bean, preferably cocoa powder, to various foods, and further added to the composition as described above. In addition, minerals such as iron and magnesium, vitamins such as vitamins C and E, and / or spices may be blended. For the addition of such a cocoa bean processed product and the mixing of optional minerals and vitamins, any technique known and commonly used by those skilled in the art may be used, and the composition of food suitable for the blending may also be determined by those skilled in the art. Any known one may be used.
[0028]
For example, the composition for improving coolness of the present invention can be in the form of food such as instant cocoa or chocolate. In this case, in the case of the instant cocoa, 15% by weight of cocoa powder having a coolability improving effect is added to sugar. 54% by weight, 10% by weight of whole fat milk powder, 20% by weight of skim milk powder, 0.5% by weight of salt, and 0.5% by weight of flavor. In addition, chocolate may be produced by any method known to those skilled in the art, in which minerals, vitamins, spices, and the like may be optionally added.
[0029]
In addition, the composition for improving cooling performance of the present invention can be prepared as an oral drug or the like.
[0030]
That is, since the processed cocoa bean product of the present invention has an excellent cooling property improving (body surface temperature increasing) action, a pharmaceutically acceptable additive may be added to the cocoa bean processed product, for example, cocoa powder, or may be added. Can be formulated together with the active ingredient of As the additive at that time, various additives usually used in the field of pharmaceutical preparations can be used, for example, gelatin, lactose, sucrose, titanium oxide, starch, crystalline cellulose, hydroxypropylmethylcellulose, carboxymethylcellulose, corn starch, and microparticles. Crystallin wax, white petrolatum, magnesium aluminate metasilicate, anhydrous calcium phosphate, citric acid, trisodium citrate, hydroxypropylcellulose, sorbitol, sorbitan fatty acid ester, polysorbate, sucrose fatty acid ester, polyoxyethylene hydrogenated castor oil, polyvinylpyrrolidone, Magnesium stearate, light silicic anhydride, talc, vegetable oil, benzyl alcohol, gum arabic, propylene glycol, polyalkylene glycol, thick Dextrin or hydroxypropyl cyclodextrin and the like.
[0031]
Dosage forms formulated as a mixture with these additives or as a mixture which may further contain any other active ingredient include, for example, solid preparations such as tablets, capsules, granules, powders and the like; or, for example, syrups And liquid preparations such as oral preparations including preparations and drinks, which can be prepared by a usual method in the field of preparations. In the case of a liquid preparation such as a syrup, it may be in the form of being dissolved or suspended in water or another appropriate medium at the time of use.
[0032]
These preparations may contain the processed cocoa bean product of the present invention in a proportion of 1 to 90% by weight, preferably 1 to 20% by weight of the whole drug.
[0033]
Thus, the composition for improving coldness of various aspects characterized by containing the processed cocoa bean product of the present invention is produced, and not only treatment / prevention of a subject in need of treatment for improving coldness but also maintenance of health of a healthy subject・ It can be used for promotion.
[0034]
Hereinafter, the present invention will be described in detail with reference to examples, but the examples do not limit the present invention in any way.
[0035]
【Example】
Example 1: Body surface temperature increasing effect by processed cocoa beans The present invention is directed to a change in body surface temperature at rest in a room where the air temperature is set to 25 ° C, assuming cooling in a cooling room in summer. The effect of ingestion of processed cocoa beans was investigated. In addition, 28 ° C. is generally recommended as the cooling temperature in summer. However, in reality, the cooling temperature is set to about 25 ° C. or more by 60% or more (including “the temperature is not particularly set”). There is also a survey result that the air conditioner occupies a certain amount of time, and in the present embodiment, such a slightly excessive cooling time is assumed for the purpose of clarifying the effect.
[0036]
The study was performed on 12 women, including subjects without the awareness of coldness. In this test, subjects were prohibited from eating and drinking 2.5 hours before the start of the test, and were also prohibited from ingesting stimulants during the morning and lunch on the day of the test. In the test, the subject was first allowed to stand in a room where the temperature was adjusted to 25 ° C. for 30 minutes and the initial body surface temperature was measured. After that, the test beverage was drunk, and thereafter, the change in body surface temperature was changed every 5 minutes. This was done by recording. During the test, the subjects were instructed to rest and not talk, move around, or sleep. In addition, a constant posture is maintained for 5 minutes before drinking the test beverage, and thereafter, the measurement is performed in that posture. In particular, the body surface temperature of the hand that is the measurement site is not affected by other factors. That is, in order to prevent the hand portion from touching anywhere, the user is instructed to sit on the arm with the arm in such a posture that the tip of the arm does not touch the arm. Furthermore, the position where the subject stands by in the room is a place where the air of the air conditioner does not directly hit, and the amount of the air is the weakest. The interior of the room was dimly lit to maintain a resting state, and a metronome was installed at 60 counts per minute to create a calm environment.
[0037]
The test was conducted at 70 to 75 ° C. using commercially available cocoa (trade name “luxurious cocoa with cocoa”, manufactured by Morinaga Seika Co., Ltd., according to the manufacturer's instructions), coffee (1 g of commercially available instant coffee powder, 3 g of granulated sugar, commercially available creamy powder). 3 g was dissolved in 100 ml of hot water), green tea (commercially available sencha drinking water) and hot water, and the subject drank 100 ml of these hot beverages while cooling appropriately. For drinking, a paper cup with wings was used, and a hand opposite to the handle of the cup was instructed not to attach to the cup. Note that three of the test subjects could not drink coffee, so the test was not performed with the test subjects. The measurement of the body surface temperature was carried out using a medical thermography device (model name: Infraeye 2000, manufactured by Fujitsu Toki System Co., Ltd.).
[0038]
Table 1 shows an outline of the evaluation of the improvement in cooling performance measured by thermography. In addition, FIG. 1 shows the average of the results of calculating the transition of the body surface temperature among the subjects by analyzing the image of the thermography measurement results. Further, FIG. A. The example of the measurement of the actual thermography was shown.
[0039]
[Table 1]
[0040]
The degree of increase in body surface temperature and its duration were evaluated by thermography as described above. As shown in Table 1, it was shown that cocoa containing the processed cocoa beans of the present invention exhibited an excellent cooling property improving effect. . In the tests, examples in which the effect of cocoa was almost equivalent to that of green tea (WT), examples in which the effect of cocoa was equivalent to that of coffee (TM), and examples in which green tea was slightly better (IM) Although some exceptions were found, most of the subjects experienced the best improvement in coldness due to ingestion of the processed cocoa bean.
[0041]
In addition, from FIG. 1, in the test of the body surface temperature, the change in the body surface temperature after drinking the test beverage is understood. In general, however, the subject once drops the body surface temperature about 5 minutes after drinking the test beverage. . Thereafter, the body surface temperature increases due to the effect of ingestion of hot foods after 10 to 20 minutes, but in the case of the cocoa containing the processed cocoa beans of the present invention, the time to maintain the increase is long, and after the drinking, the cocoa has a long time. In about a minute, a rise in body surface temperature is again observed. Although the same tendency of body surface temperature change as cocoa may be observed in other than cocoa, the temperature rise time is generally short, and it is observed whether late body temperature rise of around 40 minutes observed in the processed cocoa beans is observed. It was just a faint thing. In particular, in beverages other than cocoa, the average body surface temperature is lower than that before the start of drinking about 30 minutes before the start of drinking, but in cocoa such a decrease in body surface temperature is also 60 minutes after the start of drinking. It is noteworthy that no was recognized.
[0042]
From the above results, it was demonstrated that the processed cocoa bean product of the present invention had an excellent cooling property improving effect.
[0043]
【The invention's effect】
According to the present invention, not only the improvement of symptoms and signs of actual coldness, but also the prevention of the coldness, especially the ataxia of the body or the like due to the indoor environment in the summer when the temperature difference from the outside, which is also called cooling disease, is severe, or Including the coldness caused by the temperature difference between indoor and outdoor in winter, they can be extremely easily improved.Therefore, the composition for improving coldness of the present invention is not only effective for improving specific coldness but also for healthy people. Can also help maintain and improve their health.
[Brief description of the drawings]
FIG. 1 shows the average of changes in body surface temperature after drinking various hot beverages based on image analysis of thermography.
FIG. A. Drawing substitute photograph of measurement example of thermography in.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002180493A JP2004018512A (en) | 2002-06-20 | 2002-06-20 | Poor circulation-improving composition and use of cacao bean processed product for producing the poor circulation-improving composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002180493A JP2004018512A (en) | 2002-06-20 | 2002-06-20 | Poor circulation-improving composition and use of cacao bean processed product for producing the poor circulation-improving composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004018512A true JP2004018512A (en) | 2004-01-22 |
Family
ID=31177598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002180493A Pending JP2004018512A (en) | 2002-06-20 | 2002-06-20 | Poor circulation-improving composition and use of cacao bean processed product for producing the poor circulation-improving composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2004018512A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013237629A (en) * | 2012-05-14 | 2013-11-28 | Oriza Yuka Kk | Peripheral blood circulation disorder improving agent |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07267977A (en) * | 1994-03-31 | 1995-10-17 | I T Bi S:Kk | Glycoside from fruit essence of panax shinseng, production thereof, production of health food thereform |
JP2000069936A (en) * | 1998-09-02 | 2000-03-07 | Chugoku Kenkoho Kokusai Gakkai:Kk | Health food |
JP2001098267A (en) * | 1999-09-30 | 2001-04-10 | Kobayashi Pharmaceut Co Ltd | Antioxidant and active-oxygen eliminator |
JP2001098266A (en) * | 1999-09-30 | 2001-04-10 | Kobayashi Pharmaceut Co Ltd | Antioxidant and active-oxygen eliminator |
JP2001518928A (en) * | 1997-03-26 | 2001-10-16 | コーボニツツ,デツゾー | Antitussive composition |
-
2002
- 2002-06-20 JP JP2002180493A patent/JP2004018512A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07267977A (en) * | 1994-03-31 | 1995-10-17 | I T Bi S:Kk | Glycoside from fruit essence of panax shinseng, production thereof, production of health food thereform |
JP2001518928A (en) * | 1997-03-26 | 2001-10-16 | コーボニツツ,デツゾー | Antitussive composition |
JP2000069936A (en) * | 1998-09-02 | 2000-03-07 | Chugoku Kenkoho Kokusai Gakkai:Kk | Health food |
JP2001098267A (en) * | 1999-09-30 | 2001-04-10 | Kobayashi Pharmaceut Co Ltd | Antioxidant and active-oxygen eliminator |
JP2001098266A (en) * | 1999-09-30 | 2001-04-10 | Kobayashi Pharmaceut Co Ltd | Antioxidant and active-oxygen eliminator |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013237629A (en) * | 2012-05-14 | 2013-11-28 | Oriza Yuka Kk | Peripheral blood circulation disorder improving agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7229649B2 (en) | Method and composition for improving sexual fitness | |
JP5586815B2 (en) | Compositions and methods for the treatment of body weight conditions using milk minerals and casein fractions | |
Ödlund Olin et al. | Energy‐enriched hospital food to improve energy intake in elderly patients | |
KR100704523B1 (en) | Theanine-containing composition | |
US7115285B2 (en) | Composition and method for appetite and craving suppression and mood enhancement | |
US20070036873A1 (en) | Method of treatment or management of stress | |
JP3018053B2 (en) | Food and drink | |
Martinet et al. | Thermogenic effects of commercially available plant preparations aimed at treating human obesity | |
US7790670B2 (en) | Compositions and methods for treatment of body weight conditions | |
KR20240057401A (en) | Paraxanthin-based caffeine substitute composition and method of use thereof in slow caffeine metabolizers | |
CN106061479B (en) | Weak prophylactic | |
KR101596728B1 (en) | Composition comprising zinc/red ginseng, octacosanol and vitamin for preventing and ameliorating andropause symptoms | |
JP2007204406A (en) | Body temperature-regulating agent | |
US7371415B1 (en) | Method and composition for improving sexual fitness | |
JP2004018512A (en) | Poor circulation-improving composition and use of cacao bean processed product for producing the poor circulation-improving composition | |
JP4337273B2 (en) | Basal metabolism enhancer | |
US20120178799A1 (en) | Energy beverage with creatine and caffeine combination | |
CN104623097A (en) | Application of Pu'er tea extract in preparation of fat reducing medicines or health foods | |
TWI664975B (en) | Banana peel extract for regulating expressions oftph1gene,ddcgene and/oraanatgene, and uses of the same | |
WO2010119804A1 (en) | Anti-mental fatigue agent | |
WO2018124202A1 (en) | Perspiration-promoting food composition | |
US20140242202A1 (en) | Composition for Reducing Side- and After-Effects of Cancer Treatment | |
US20020187179A1 (en) | Non-steroidal anabolic compositions and associated methods | |
JP3314061B2 (en) | Coffee beverages and processed beverages thereof, and additive preparations for coffee | |
KR20160075431A (en) | Composition of balanced nutrition for improving frailty and geriatric syndrome and method for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050207 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081226 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090217 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090410 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090521 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090619 |